News
BSX
86.20
-0.58%
-0.50
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe
NASDAQ · 10h ago
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
Benzinga · 1d ago
Goldman sees a ‘relief rally’ potential for these option calls ahead of earnings
Seeking Alpha · 1d ago
InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent
NASDAQ · 1d ago
CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica
NASDAQ · 1d ago
Is Boston Scientific (NYSE:BSX) A Risky Investment?
Simply Wall St · 1d ago
Axonics gains after Boston Scientific says it will end use of Coaptite on Nov. 1
Seeking Alpha · 2d ago
Integer Holdings (ITGR) Gains 30.5% YTD: What's Driving the Stock?
NASDAQ · 2d ago
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?
Barchart · 2d ago
Should You Add Quest Diagnostics Stock to Your Portfolio Right Now?
NASDAQ · 2d ago
Earnings Preview: What To Expect from Boston Scientific's Report
Barchart · 2d ago
Boston Scientific (BSX) Gets a Buy from Bank of America Securities
TipRanks · 3d ago
Boston Scientific Is Maintained at Outperform by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Outperform on Boston Scientific, Raises Price Target to $95
Benzinga · 3d ago
Robust Plasma Sales, New Innovations Aid Haemonetics Stock
NASDAQ · 3d ago
AMN Stock Down Despite WorkWise Launch to Enhance Healthcare Delivery
NASDAQ · 3d ago
PRCT Stock Rises on FDA's Nod to Initiate Study on Prostate Cancer
NASDAQ · 3d ago
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
NASDAQ · 3d ago
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
NASDAQ · 3d ago
Boston Scientific price target raised to $95 from $85 at RBC Capital
TipRanks · 3d ago
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.